ArticleFolia microbiologica2026
Identification and phylogenetic analysis of Mannheimia haemolytica isolated from nasal samples of horses.
Article in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Mannheimia genus, which is part of the upper respiratory tract microbiota, harbours species that have the potential to cause progressive infections, such as haemorrhagic septicaemia and enzootic pneumonia, when the host immune system is suppressed. Among these species, Mannheimia haemolytica is considered the most pathogenic, and horses can be a host for this agent. This study aimed to investigate the occurrence of Mannheimia haemolytica in horses with and without respiratory clinical signs and to assess the potential pathogenic significance of isolates recovered from animals through serotyping, detection of virulence-associated genes, and phylogenetic analysis. In this study, a total of 134 nasal swab samples were collected from horses reared in 15 farms in five provinces of Türkiye. Of these animals, 20 exhibited clinical signs of respiratory disease, while 114 were clinically healthy. All samples were analysed using cultural, phenotypic, and molecular methods for the detection of M. haemolytica. Ten (7.46%) isolates were identified as M. haemolytica by culture and subsequently confirmed by 16 S rDNA-PCR analysis. All M. haemolytica isolates were obtained exclusively from horses with clinical signs such as high fever, lethargy, loss of appetite, rhinorrhea, and coughing. Serotyping revealed that nine isolates belonged to Serotype 2 and one to Serotype 1. The leukotoxin (lkt) gene was detected in only one (11.11%) Serotype 2 isolate. Similarly, the Ssa-1 protein gene was detected in one Serotype 1 strain. One Serotype 2 isolate carrying the lktCABD operon clustered closely with leukotoxin-associated sequences of both M. haemolytica and M. glucosida, while remaining consistent with its independently established species identity. These findings indicate that M. haemolytica, including strains carrying virulence-associated markers, can be recovered from the upper respiratory tract of horses exhibiting respiratory disease. The exclusive recovery of M. haemolytica from clinically affected horses suggests a potential association with equine respiratory disease, although its causal role requires further investigation.
Indexed as
Identifiers
42690607What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.